This is the authors' abstract. We don't add key points for this paper.
Diabetic wounds are the most common complication of diabetes, contributing to severe health costs and economic losses [ 1 ]. Over 1 million patients with diabetes present with diabetic wounds [ 2 , 3 ]. Therefore, developing new wound dressings is essential for treating diabetic wounds [ 4 ]. However, treating diabetic wounds remains challenging because a high-glucose microenvironment can further induce bacterial breeding, resulting in infection-related complications [ 2 , 5 ]. Microangiopathy and revascularization defects can also negatively influence healing [ 6 , 7 ]. The infections and defects of vessels might further trigger a chain of adverse reactions, such as inhibition of cell proliferation and migration [ 8 , 9 ].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: